Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Borras

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 5, 2003
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factorsR Molina, X Filella, J M Augé, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 17, 2013
Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian modelsJ Ribes, L Esteban, R Clèries, et al.
Actas Dermo-Sifiliograficas|December 14, 2025
Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From SpainJ F Silvestre-Salvador, S Santos-Alarcón, A Mengual-Sendra, et al.
Clinical Epigenetics|January 15, 2021
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survivalM Cabezón, R Malinverni, J Bargay, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 5, 2003
Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factorsR Molina, X Filella, J M Augé, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 17, 2013
Cancer incidence and mortality projections up to 2020 in Catalonia by means of Bayesian modelsJ Ribes, L Esteban, R Clèries, et al.
Actas Dermo-Sifiliograficas|December 14, 2025
Long-term Persistence, Safety and Efficacy Profile of Dupilumab in Atopic Dermatitis: A Real-world Retrospective Multicenter Study From SpainJ F Silvestre-Salvador, S Santos-Alarcón, A Mengual-Sendra, et al.
Clinical Epigenetics|January 15, 2021
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survivalM Cabezón, R Malinverni, J Bargay, et al.
Pageof 2